516 related articles for article (PubMed ID: 29636082)
1. Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis.
Kawaguchi H; Matsumoto I; Osada A; Kurata I; Ebe H; Tanaka Y; Inoue A; Umeda N; Kondo Y; Tsuboi H; Shinkai Y; Kumagai Y; Ishigami A; Sumida T
Arthritis Res Ther; 2018 Apr; 20(1):66. PubMed ID: 29636082
[TBL] [Abstract][Full Text] [Related]
2. Citrullinated inter-alpha-trypsin inhibitor heavy chain 4 in arthritic joints and its potential effect in the neutrophil migration.
Osada A; Matsumoto I; Mikami N; Ohyama A; Kurata I; Kondo Y; Tsuboi H; Ishigami A; Sano Y; Arai T; Ise N; Sumida T
Clin Exp Immunol; 2021 Mar; 203(3):385-399. PubMed ID: 33238047
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic Role of Circulating Citrullinated Antigens and Anti-Cyclic Monoclonal Citrullinated Peptide Antibodies in Rheumatoid Arthritis.
Won P; Kim Y; Jung H; Rim YA; Sohn DH; Robinson WH; Moon SJ; Ju JH
Front Immunol; 2021; 12():692242. PubMed ID: 34305925
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)(542-556) peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis.
Liao CC; Chou PL; Cheng CW; Chang YS; Chi WM; Tsai KL; Chen WJ; Kung TS; Tai CC; Lee KW; Chen YC; Lin CY
J Proteomics; 2016 Jun; 141():1-11. PubMed ID: 27072115
[TBL] [Abstract][Full Text] [Related]
5. Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis.
Markovics A; Ocskó T; Katz RS; Buzás EI; Glant TT; Mikecz K
PLoS One; 2016; 11(7):e0160284. PubMed ID: 27466816
[TBL] [Abstract][Full Text] [Related]
6. Citrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis.
Ohara RA; Edhayan G; Rasmussen SM; Isozaki T; Remmer HA; Lanigan TM; Campbell PL; Urquhart AG; Lawton JN; Chung KC; Fox DA; Ruth JH
Arthritis Rheumatol; 2019 Aug; 71(8):1241-1251. PubMed ID: 30861322
[TBL] [Abstract][Full Text] [Related]
7. Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis.
Shoda H; Fujio K; Shibuya M; Okamura T; Sumitomo S; Okamoto A; Sawada T; Yamamoto K
Arthritis Res Ther; 2011; 13(6):R191. PubMed ID: 22108001
[TBL] [Abstract][Full Text] [Related]
8. Anti -citrullinated peptide antibodies profiling in established rheumatoid arthritis.
Manca ML; Alunno A; D'Amato C; Bistoni O; Puxeddu I; Gerli R; Migliorini P; Pratesi F
Joint Bone Spine; 2018 Jul; 85(4):441-445. PubMed ID: 28826660
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach.
Matsuo K; Xiang Y; Nakamura H; Masuko K; Yudoh K; Noyori K; Nishioka K; Saito T; Kato T
Arthritis Res Ther; 2006; 8(6):R175. PubMed ID: 17125526
[TBL] [Abstract][Full Text] [Related]
10. Peptidyl arginine deiminase inhibition suppresses arthritis via decreased protein citrullination in joints and serum with the downregulation of interleukin-6.
Kawaguchi H; Matsumoto I; Osada A; Kurata I; Ebe H; Tanaka Y; Inoue A; Umeda N; Kondo Y; Tsuboi H; Ishigami A; Sumida T
Mod Rheumatol; 2019 Nov; 29(6):964-969. PubMed ID: 30285515
[No Abstract] [Full Text] [Related]
11. Role of inter-alpha-trypsin inhibitor heavy chain 4 and its citrullinated form in experimental arthritis murine models.
Iwai T; Ohyama A; Osada A; Nishiyama T; Shimizu M; Miki H; Asashima H; Kondo Y; Tsuboi H; Mizuno S; Takahashi S; Ishigami A; Matsumoto I
Clin Exp Immunol; 2024 Feb; 215(3):302-312. PubMed ID: 38190323
[TBL] [Abstract][Full Text] [Related]
12. Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis.
Schwenzer A; Jiang X; Mikuls TR; Payne JB; Sayles HR; Quirke AM; Kessler BM; Fischer R; Venables PJ; Lundberg K; Midwood KS
Ann Rheum Dis; 2016 Oct; 75(10):1876-83. PubMed ID: 26659718
[TBL] [Abstract][Full Text] [Related]
13. Fine specificity of anti-citrullinated peptide antibodies discloses a heterogeneous antibody population in rheumatoid arthritis.
Goules JD; Goules AV; Tzioufas AG
Clin Exp Immunol; 2013 Oct; 174(1):10-7. PubMed ID: 23711220
[TBL] [Abstract][Full Text] [Related]
14. Antihomocitrullinated fibrinogen antibodies are specific to rheumatoid arthritis and frequently bind citrullinated proteins/peptides.
Scinocca M; Bell DA; Racapé M; Joseph R; Shaw G; McCormick JK; Gladman DD; Pope J; Barra L; Cairns E
J Rheumatol; 2014 Feb; 41(2):270-9. PubMed ID: 24429169
[TBL] [Abstract][Full Text] [Related]
15. Characterization and Localization of Citrullinated Proteoglycan Aggrecan in Human Articular Cartilage.
Glant TT; Ocsko T; Markovics A; Szekanecz Z; Katz RS; Rauch TA; Mikecz K
PLoS One; 2016; 11(3):e0150784. PubMed ID: 26943656
[TBL] [Abstract][Full Text] [Related]
16. Serum IgG ACPA-IgM RF immune complexes were detected in rheumatoid arthritis patients positive for IgM ACPA.
Haraguchi A; Yamada H; Kondo M; Okazaki K; Fukushi JI; Oyamada A; Yoshikai Y; Nakashima Y
Clin Exp Rheumatol; 2018; 36(4):612-618. PubMed ID: 29465353
[TBL] [Abstract][Full Text] [Related]
17. Citrullination of synovial proteins in murine models of rheumatoid arthritis.
Vossenaar ER; Nijenhuis S; Helsen MM; van der Heijden A; Senshu T; van den Berg WB; van Venrooij WJ; Joosten LA
Arthritis Rheum; 2003 Sep; 48(9):2489-500. PubMed ID: 13130468
[TBL] [Abstract][Full Text] [Related]
18. Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps.
Pratesi F; Dioni I; Tommasi C; Alcaro MC; Paolini I; Barbetti F; Boscaro F; Panza F; Puxeddu I; Rovero P; Migliorini P
Ann Rheum Dis; 2014 Jul; 73(7):1414-22. PubMed ID: 23727635
[TBL] [Abstract][Full Text] [Related]
19. Inter-alpha-trypsin inhibitor heavy chain 4: A serologic marker relating to disease risk, activity, and treatment outcomes of rheumatoid arthritis.
He K; He S; Su M
J Clin Lab Anal; 2022 Mar; 36(3):e24231. PubMed ID: 35064701
[TBL] [Abstract][Full Text] [Related]
20. Citrullination of fibronectin in rheumatoid arthritis synovial tissue.
Chang X; Yamada R; Suzuki A; Kochi Y; Sawada T; Yamamoto K
Rheumatology (Oxford); 2005 Nov; 44(11):1374-82. PubMed ID: 16105911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
